Project Grant R01HL173940
Award Date
9/1/24
Completion Date
6/30/29
Dollars Obligated
$799K
Federal Agency
National Heart Lung and Blood Institute
Federal Grant Program
93.837
Assistance Type
Project Grant
Place of Performance
Chicago, IL 60611, USA
Similar Awards
This federal Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI), under the Cardiovascular Diseases Research program (CFDA 93.837), provides $2,803,961 to Northwestern University to conduct research focused on integrated mechanisms of primary and chronic graft dysfunction following lung transplantation. The award, which began on September 17, 2024 and runs through July 31, 2029, supports four interrelated research projects. These projects aim to: 1) determine how...
This Project Grant award of $798,958 from the National Heart, Lung, and Blood Institute (NHLBI), under the Cardiovascular Diseases Research program (CFDA 93.837), supports research to understand the molecular mechanisms linking acute lung injury after transplantation to the development of chronic lung allograft dysfunction. The research will be conducted by Northwestern University and aims to determine whether activation of the integrated stress response in the airway and alveolar epithelium...
This federal Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI), under the Cardiovascular Diseases Research program (CFDA 93.837), provides $616,000.00 to Northwestern University over a 5-year period beginning September 1, 2024. The grant supports research to investigate the role of mitochondrial metabolism and the integrated stress response in alveolar epithelial cell differentiation, with the goal of understanding the mechanisms driving heterogeneous outcomes in...
This $747,239 federal Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI), under the Cardiovascular Diseases Research program (CFDA 93.837), supports research on the role of plasma cells in chronic rejection after lung transplantation. The grant recipient, the University of Pittsburgh, aims to: Comprehensively map the gene expression profiles, population heterogeneity, and temporal dynamics of B and plasma cell populations in chronically rejected lungs after lung...
This $1,875,540 Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI), under the Cardiovascular Diseases Research federal grant program (CFDA 93.837), aims to investigate the role of perivascular macrophages in promoting endothelial cell regeneration and vascular repair following acute lung injury or acute respiratory distress syndrome (ARDS). The key objectives are to (1) determine how perivascular macrophages regulate endothelial cell regeneration and vascular repair...
This $350,546 project grant from the Department of Health and Human Services National Institutes of Health National Heart Lung and Blood Institute will support research into natural killer cells and pulmonary ischemia-reperfusion injury. The Regents of the University of California, San Francisco will investigate the role of natural killer cells in primary graft dysfunction following lung transplantation through three specific aims: determining how natural killer cells are activated and induce...
This Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI), under the Cardiovascular Diseases Research Federal Grant Program (CFDA 93.837), supports research to develop an imaging-compatible pre-clinical ex vivo lung perfusion (EVLP) system. The goal is to obtain structural, functional, and metabolic biomarkers that can be used to optimize EVLP parameters and assess donor lungs with common defects like atelectasis, ventilator-induced lung injury, and reperfusion...
This Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI), under the Cardiovascular Diseases Research program (CFDA 93.837), provides $750,162 to The Children's Hospital of Philadelphia (CHOP) to conduct research on lymphatic dysfunction and the development of post-lung transplant obliterative bronchiolitis. The key objectives are to: 1) determine the mechanisms of lymphatic vascular function after lung transplantation, 2) develop strategies to promote lymphangiogenesis...
This $775,992 Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI), under the Cardiovascular Diseases Research Federal Grant Program (CFDA 93.837), supports research to investigate the role of regulatory T cells (Tregs) and glucocorticoid signaling in the resolution of acute lung injury (ALI) and the impact of host genetic variability. The key objectives are to: Determine the function of Treg glucocorticoid receptor (GR) signaling and the effects of exogenous...
This $163,080 Project Grant awarded by the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837) aims to study the regulatory T cell (Treg) response in children with severe viral pneumonia. The grant supports research to determine if Treg cells have impaired reparative functions during severe viral pneumonia in children, assess how the lung microenvironment affects Treg pro-recovery functions, and identify Treg transcriptional...